To confirm the incorporation of MLL fusions into EAP also in authentic leukemia cells, the immunoprecipitation experiments were repeated with SEM cells, a B-ALL line transformed by MLL-AF4 [34]. The gene discussed is KMT2A; the disease is acute lymphoblastic leukemia.